GLOBAL
Corporate Governance
Alnylam employees, officers, and directors are held to high standards set by our Board of Directors.
These standards and procedures can be found in the following guidelines.
Governance Guidelines
Charters
| Type | View/Download |
|---|---|
| Nominating and Corporate Governance Committee Charter | |
| Compensation Committee Charter | |
| Audit Committee Charter | |
| Science and Technology Committee Charter |
Management Board
We have passionate leaders from the biopharmaceutical industry who bring together their experiences
of drug discovery, drug development, and commercialization.
John Maraganore, PhD
Chief Executive Officer
Barry Greene
President
Jeff Poulton
Chief Financial Officer
Yvonne Greenstreet, MBChB, MBA
Chief Operating Officer
Pushkal Garg, MD
Chief Medical Officer
Laurie Keating, JD
EVP, Chief Legal Officer and Secretary
Saraswathy V. Nochur, PhD
SVP, Chief Regulatory Officer
Akshay Vaishnaw, MD, PhD
President, Research & Development
Kelley Boucher
Chief Human Resource Officer
Board of Directors
We have a team of accomplished leaders from various backgrounds who elevate our initiatives and strategies.
Chair of the Board: Michael W. Bonney
Audit Committee
Michael W. Bonney
Marsha H. Fanucci, Chair
Colleen Reitan
Created to assist the Board of Directors’ oversight of the Company’s accounting and financial reporting processes and the audits of the Company’s financial statements.
Compensation Committee
Steven M. Paul, M.D.
Paul R. Schimmel, Ph.D.
Amy W. Schulman, Chair
Designed to assist the Board of Directors in the discharge of its responsibilities relating to compensation of the Company’s executive officers.
Nominating and Corporate Governance Committee
Dennis A. Ausiello, M.D.
Michael W. Bonney
Marsha H. Fanucci
David E.I. Pyott,
Chair
Amy W. Schulman
Recommends to the Board the persons to be nominated for election as directors at any meeting of stockholders; develop and recommend to the Board a set of corporate governance principles applicable to the Company; and oversee the evaluation of the Board.
Science and Technology Committee
Dennis A. Ausiello, M.D.
Steven M. Paul, M.D.
Paul R. Schimmel, Ph.D.
Phillip A.
Sharp, Ph.D., Chair
Assists the Board’s oversight of the Company’s research and development activities and to advise the Board with respect to strategic and tactical scientific issues.
Looking for specific information that isn't listed above?
Contact: investors@alnylam.com